{"podcast":{"title":"DOC Updates","slug":"doc-updates-200053","podcast_index_feed_id":200053,"rss_url":"https://diabetescoreupdate.libsyn.com/rss","website_url":"http://diabetescoreupdate.libsyn.com","image_url":"https://static.libsyn.com/p/assets/7/5/1/2/751262fede9556bed959afa2a1bf1c87/Podcasts_DOC_Updates_Final_teal_1400x1400.jpg","author":"American Diabetes Association","episode_count":100,"summary":"DOC Updates is a monthly podcast that presents and discusses the latest clinically relevant articles in the field of diabetes research and care, including the American Diabetes Association's three science and health journals – Diabetes, Diabetes Care, and Diabetes, Obesity, and Cardiometabolic CARE. Each episode is approximately 15 minutes long and presents 5-6 recently published articles from ADA journals and beyond. Intended for practicing physicians and health care professionals, DOC Updates discusses how the latest research and information published in journals of the American Diabetes Association and beyond are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Clinical Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency…","last_synced_at":"2026-09-25T04:18:08.178503+00:00","page_url":"https://stenobird.com/podcast/doc-updates-200053"},"episode":{"title":"Efficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more!","slug":"efficacy-and-safety-of-cagrisema-retatrutide-cgm-benefits-beyond-t2d-more","published_at":"2026-06-30T14:24:00+00:00","page_url":"https://stenobird.com/podcast/doc-updates-200053/efficacy-and-safety-of-cagrisema-retatrutide-cgm-benefits-beyond-t2d-more","show_page_url":"https://stenobird.com/podcast/doc-updates-200053","url":"https://diabetescoreupdate.libsyn.com/efficacy-and-safety-of-cagrisema-retatrutide-cgm-benefits-beyond-t2d-more","audio_url":"https://traffic.libsyn.com/secure/diabetescoreupdate/Diabetes_Core_Update_July_2026.mp3?dest-id=159994","summary":"Welcome to the latest episode (July 2026) of DOC Updates , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Updates : Aroda V, Buzzetti R, Dalskov S et al. \" Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study .\" The Lancet Diabetes & Endocrinology, 2026; 0 doi: 10.1016/S2213-8587(26)00126-9 Bajaj H, Welch M, Shah P et al. \" Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial .\" The Lancet, 2026; 407, 2402-2413 doi: 10.1016/S0140-6736(26)00967-0 Melville, N. \" CGM Monitoring Benefits Extend to Non-Insulin-Using T2D .\" Medscape, June 07, 2026 Aronne, L.J., Horn, D.B., le Roux, C.W. et al. \" Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial .\" Nat Med(2026) doi: 10.1038/s41591-026-04386-7 Salive ME, Tjaden AH, Ames JR, et al. \" Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes .\" JAMA. Published online June 15, 2026. doi: 10.1001/jama.2026.8492 Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medi…","meta_description":"Welcome to the latest episode (July 2026) of DOC Updates , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on d…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2070,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/efficacy-and-safety-of-cagrisema-retatrutide-cgm-benefits-beyond-t2d-more/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/doc-updates-200053/efficacy-and-safety-of-cagrisema-retatrutide-cgm-benefits-beyond-t2d-more.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}